Ending Disparities

As the United States Conference on AIDS (USCA 2015) will convene shortly (September 10–13) in Washington, D.C.—and its theme is “The Numbers Don’t Lie:...

The Road Ahead

LifeGuide Treatment Horizons The Road Ahead New candidates hold promise for ARV therapy & therapeutic vaccines by Mariel Selbovitz, MPH The 54th Interscience Conference on Antimicrobial Agents and Chemotherapy...

Global HIV and COVID-19 Emergency Response Fund

Global HIV and COVID-19 Emergency Response Fund On April 27, 2020, ViiV Healthcare announced the creation of £3-million Global HIV and COVID-19 Emergency Response Fund...

Verve for VERxVE

An extended release formulation breaks through by Chael Needle Based on results from the VERxVE study, the FDA recently approved Viramune XR for use in antiretroviral...

HIV Therapeutic Vaccine Advances

Treatment Horizons Another Kind of Morning HIV therapeutic vaccines try to come of age by Mariel Selbovitz, MPJ, and David Miller Despite over three decades of research on...

HPV Immunotherapy Research

Warts & All An immunotherapy candidate seeks to address complications from HPV by Chael Needle Human papillomavirus (HPV) is the most common sexually transmitted infection, but, according...

PRO 140

Chronic Relief? A self-injectable monoclonal antibody vies to become a monotherapy by Chael Needle Anti-HIV agents currently being researched these days seem split between (1) improving regimens...

Heart Break in Melbourne

LifeGuide Heart Break in Melbourne Cardiovascular disease studies focus on assessment, management & treatment by Jeannie Wraight Cardiovascular disease (CVD) has become a leading cause of illness and...

LATEST POSTS

Elizabeth, Larry & Diana

Three Heroes Honoring Dame Elizabeth Taylor, Larry Kramer and Princess Di by John Francis Leonard When we recently lost that great man of letters and prominent activist,...

Don’t Shoot

Stay Angry and Make Trouble

In an Instant